The available data obtained from the samples by the Q-TOF-MS were searched against the 178 animal species sub-directory of the SwissProt.Holothuridae.January2017.1047.fasta 179 database (UniProt, EBI, UK) using the SpectrumMill search engine (SpectrumMill 180 Rev.B.04.00.127, Agilent Technologies). Basic parameters were set at a precursor mass 181 tolerance of 10 ppm, a product mass tolerance of 50 ppm and a 'no-enzyme' constraint.
182
Peptides with score above 6 and a percentage of scored peak intensity higher than 50%
183
were considered a match. Captopril and the five potent stone fish protein hydrolysates-derived peptides were selected 235 as ligands. All the peptides were managed using energy minimizing module while the deviations from triplicate observations. Significant difference was then determined using
257
Tukey's significance test, at p < 0.05. 
Results and Discussion

264
Fractionation of Stone Fish Protein Hydrolysates Produced under Optimum
265
Hydrolysis Conditions and Analysis of Peptide Sequence and ACE-inhibitory Activity
266
The stone fish-derived ACE-inhibitory hydrolysates generated under the optimum 267 conditions of pH 7, temperature 40°C, E/S 2% and time 240 min were sequentially 268 fractionated based on their hydrophobicity and isoelectric properties using RP-HPLC and
269
IEF-electrophoresis, respectively. The constituent peptides were then identified by QTOF-
270
LC/MS and evaluated for ACE-inhibitory effects.
271
Firstly, a semi-preparative reverse-phase high performance liquid chromatography (RP- highly hydrophobic peptides fractions were separated at later stage. The ACE-inhibitory 281 activity of each fraction was determined as previously described.
282
As shown in Figure 1b , no ACE-inhibitory activity was detected in the first 7 fractions. Secondly, the RP-HPLC fractions 10, 11, 17, 18, and 20 with the highest ACE-inhibitory 308 activity were selected and further fractionated based on their isoelectric properties by a 309 system of OFFGEL fractionation using IEF-electrophoresis (Table 1) . fractions at different isoelectric points along a pH gradient (3-10).
326
Lastly, the IEF sub-fractions 11, 9, 1, 2 and 9 from the RP-HPLC fractions 10, 
330
The selected IEF sub-fractions were subjected to Q-TOF LC/MS for the sequencing and 331 identification of the potent peptides based on amino acids composition. The process involved a system of U-HPLC coupled to a Q-TOF mass spectrometer to separate and 333 identify the individual peptide sequences present.
334
The results for the MS/MS spectra, ion tables, MS/MS fragments and standard error of the 335 potent peptide sequences with mw < 1000 Da are shown in Figure 3 .
336
The identification, peptide sequence molecular formula confirmation and molecular ions As shown in Table 2 
386
The positively charged amino acids arginine (R) and lysine (K) present at the C-terminal 387 were also found to contribute to the ACE inhibitory potency of peptides (29). Thus, the 388 observed differences in the ACE-inhibitory capacity exhibited by peptides can be attributed 389 to the amino acids composition of their C and N terminal tripeptides (8).
390
According to our finding, the five peptides contained QFY, PKA, PTM, LIQ and PVL as at its C-terminus could exert higher inhibitory activity against ACE (41).
In a related finding, bromelain-generated peptide sequence Ala-His-Leu-Leu with high 421 ACE-inhibitory effect (IC 50 of 18.2 ± 0.9 μg/mL) has been reported from Misgurnus and maintained higher bioavailability (45).
431
Even though the structure-activity relationship has not been well established for ACE-432 inhibitory peptides, it can be reliably stated that the inhibitory capacity of the peptides is 433 greatly influenced by composition and orientation of amino acids within their sequences.
435
In silico molecular docking of the inhibitory peptides and ACE
437
In the present study, a GlideXP software (Schrödinger, LLC) was use to dock ACE- 
471
The atomic interactions between the amino acids residues of the peptides and that from the and highest magnitude of the negative GlideScore via shorter C-terminal carbonyl oxygen -
479
Zn 2+ interaction and stronger atomic interaction between its amino acids side chain residues 480 and those on ACE within a 3.5 Å distance.
481
The 2D structures presented in Figure 4 In Figure 4 ( observed differences in the ACE-inhibitory effects of the peptides was found to be affected 527 by their C and N terminal tripeptide sequences based on structure-activity relationship.
528
Moreover, molecular docking studies showed that the peptide-ACE docking complex is 
